CRVS: the balance sheet

MyFinsight

For the quarter ending 2026-03-31, CRVS has $253,195K in assets. $12,516K in debts. $40,102K in cash and cash equivalents.

Balance Sheets	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Marketable securities	-	-	62,822	59,716
Cash and cash equivalents	40,102	4,576	2,867	14,691
Marketable securities	196,612	52,174	-	-
Accounts receivable	43	37	32	86
Prepaid and other current assets	3,189	1,427	1,223	1,287
Total current assets	239,946	58,214	66,944	75,780
Property and equipment, net	282	220	221	249
Operating lease right-of-use asset	751	839	927	1,012
Investment in angel pharmaceuticals	10,496	10,991	11,530	11,794
Other assets	1,720	855	852	626
Total assets	253,195	71,119	80,474	89,461

Accounts payable	4,697	2,491	1,974	3,137
Operating lease liability	428	403	379	355
Accrued and other liabilities	6,985	6,486	5,721	5,013
Total current liabilities	12,110	9,380	8,074	8,505
Operating lease liability	406	534	632	728
Total liabilities	12,516	9,914	8,706	9,233
Common stock 0.0001 par value 290,000,000 shares authorized at march 31, 2026 and december 31, 2025 84,090,424 and 74,696,629 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively	8	7	7	7
Additional paid-in capital	667,782	474,387	472,793	471,184
Accumulated other comprehensive loss	-1,126	-896	-1,060	-1,148
Accumulated deficit	-425,985	-412,293	-399,972	-389,815
Total stockholders' equity	240,679	61,205	71,768	80,228
Total liabilities and stockholders' equity	253,195	71,119	80,474	89,461

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.